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Abstract
Introduction: Idiopathic myelofibrosis is a chronic myeloproliferative disorder characterized by
leukoerythroblastosis, massive splenomegaly, and increases in the reticular and collagen fibers in the bone marrow.
Portal hypertension is observed in some patients with idiopathic myelofibrosis. Gastrointestinal hemorrhages, which
are due mostly to the rupture of the esophageal varices, have been sporadically reported to be an infrequent
complication of idiopathic myelofibrosis.
Case presentation: We report a case of a Japanese 63-year-old woman with myelofibrosis and variceal
hemorrhage, with a background of concomitant portal and pulmonary hypertension. She was successfully treated
through a combination of endoscopic variceal ligation and chemotherapy.
Conclusion: This is the first known report on the successful application of endoscopic variceal ligation and
chemotherapy as the therapeutic procedure for an esophageal variceal hemorrhage in a patient with myelofibrosis.
Introduction
Myelofibrosis, one of the chronic myeloproliferative dis-
orders, is characterized by a massive splenomegaly, leu-
koerythroblastosis, and increased reticular and collagen
fibers in the bone marrow [1,2]. Portal hypertension has
been observed in 10% to 17% of patients with idiopathic
myelofibrosis (IMF) [1,2]. A gastrointestinal hemorrhage,
which is due mostly to the rupture of the esophageal
varices, has been sporadically reported to be an infre-
quent complication of IMF [3-6]. However, the manage-
ment of variceal bleeding can be complicated as
esophageal varices could be caused by portal hyperten-
sion, which is a complication of extramedullary hemato-
poiesis in IMF. In this case report, we present the
usefulness of endoscopic variceal ligation and combined
chemotherapy not only for variceal bleeding but also for
the prevention of recurrence of esophageal varices.
Case presentation
A 63-year-old Japanese woman was diagnosed with IMF
in 1994 and was since treated with hydroxycarbamide.
She was admitted to our hospital on January 22, 2008,
with melena. On admission, her consciousness was
clear. Her physical status was moderate and her nutri-
tion was good. She had a blood pressure of 104/56
mmHg and a heart rate of 74 beats/min. Anemia was
observed on her palpebral conjunctivae, and jaundice
was observed on her bulbar conjunctivae. The laboratory
findings were as follows: hemoglobin 7.5 g/dl, platelets
144 × 109/L, white blood cells 2.52/μl, total protein 7.0
g/dl, and albumin 3.9 g/dl. Her peripheral blood smear
pattern showed a possible presence of myeloproliferative
disease such as immature myeloid cells, teardrop-shaped
cells, and giant platelets.
A liver chemistry revealed the following (Table 1,
Additional file 1): aspartate aminotransferase to alanine
aminotranferase (AST/ALT) of 17/17 IU/l, alkaline
phosphatase (ALP) of 771 IU/l, lactate dehydrogenase
(LDH) of 525 IU/l, and T-Bil and D-Bil markers of 2.63/
0.76 mg/dl. Hepatitis B and C virus markers were
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negative. On palpation, her abdomen revealed a mark-
edly enlarged spleen. A contrast-enhanced computed
tomography (CT) scan showed mild hepatomegaly and a
markedly severe splenomegaly with dilatation of the
splenic vein. An emergency endoscopy showed esopha-
gogastric varices (Li F2 Cb RC (+), Lg-cf F1 RC (-)) (Fig-
ure 1). A white thrombus was detected on the middle of
the esophageal varices.
The first endoscopic variceal ligation (EVL) with one
rubber band was carried out successfully on the first day
of her admission. Another endoscopic ligation was per-
formed for the remaining varices 41 days after her
admission (Figure 2). In order to eradicate the cause of
her varices, the extramedullary hematopoiesis was trea-
ted by chemotherapy (hydroxycarbamide, prednisolone
and melphalan). After the chemotherapy, her
Figure 1 Esophagogastroscopy on admission. (a) Endoscopic picture shows esophagogastric varices (Li F2 Cb RC (+), Lg-cf F1 RC (-). (b)
White thrombus was observed on the middle of the esophageal varices. (c) The first session of variceal ligation with one rubber band was
carried out successfully. (d) Endoscopic picture shows the banded varices 5 days after the first variceal ligation.
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splenomegaly improved without the recurrence of eso-
phagogastric varices (Figure 3 and Figure 4).
Discussion
In the fibrotic stage of IMF, bone marrow fibrosis
results in an ineffective erythropoiesis, thus leading to
extramedullary hematopoiesis mainly in the spleen and
the liver. We attributed our patient’s elevated hepatic
venous pressure gradient to the significantly increased
wedge hepatic venous pressure, which reflected her pro-
foundly increased intrahepatic sinusoidal resistance.
According to results of the splanchnic hemodynamics,
which was based on radiological and histological find-
ings, we proposed that obstructed sinusoidal spaces sec-
ondary to multiple extramedullary hematopoiesis in the
spleen and the liver had a partial role in the develop-
ment of portal hypertension in our patient. Although an
increased splenic blood flow may not be the only
mechanism for the development of portal hypertension
in our patient, an extremely enlarged spleen may be the
main site of red blood cell production. Therefore, an
operation with a high risk or radiation for the purpose
of a splenectomy might be a poor choice. Although we
could have also considered a transjugular intrahepatic
porto-systemic shunt (TIPS) [7,8], we chose to perform
endoscopic therapy rather than TIPS because of our
patient’s acute variceal bleeding.
Portal hypertension in patients with IMF may have
various causes, such as thrombosis of the hepatic vein,
thrombosis of the portal vein, or infiltration of myeloid
cells in the liver or spleen [5,9,10]. Any one of these
mechanisms might cause intrahepatic portal hyperten-
sion followed by variceal bleeding as the complication.
Compared to endoscopic injection variceal sclerother-
apy, EVL has been reported to have an equal efficacy
with lower therapeutic invasion and complications for
the management of esophageal variceal hemorrhages
[11].
EVL is increasingly used because of its safety and sim-
plicity, and without the necessity of using a sclerosant.
A complete eradication of the esophageal varices in our
patient was achieved after EVL was performed. How-
ever, this therapy is not thought to be a curative treat-
ment for this case because the cause of esophageal
varices could be portal hypertension as a complication
of extramedullary hematopoiesis in IMF. Therefore, we
combined chemotherapy, as shown in Figure 4.
As a result, the size of the modified spleen index
decreased and the extramedullary hematopoiesis was
suppressed after we increased our patient’s dose of
hydroxycarbamide to 2000 mg/day. However, the num-
ber of blood cells in our patient increased after it had
been discontinued. Therefore, prednisolone and melpha-
lan were added to her medication. The extramedullary
hematopoiesis was well controlled by this regimen, and
her splenomegaly also improved. There has been neither
a recurrence of esophageal varices nor deterioration in
our patient’s hematological problem.
In our patient, the portal hypertension was caused by
extramedullary (mainly splenic) hematopoiesis. Since
Figure 2 Abdominal computed tomography. Dilated splenic vein with massive splenomegaly was demonstrated by a computed tomography
scan.
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Figure 3 Endoscopic findings before and after additional endoscopic therapy for the remaining varices. (a) Endoscopic picture shows
the remaining esophagogastric varices 41 days after the patient’s admission (Ls F3 Cb RC (+), Lg-c F1 Cw RC (-); a variceal ligation with seven
rubber bands was carried out. (b) Resolving esophageal varices (Lm F1 Cb RC (-), Lg (-) were observed 1 week after the ligation. (c) Markedly
improved endoscopic findings 4 months after the variceal ligation treatment. The varices were completely eradicated.
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variceal hemorrhaging is an infrequent fatal complica-
tion of myelofibrosis, EVL could be considered as ther-
apy of variceal hemorrhages. Moreover, controlling IMF
by chemotherapy is an essential treatment for the man-
agement of portal hypertension.
Conclusion
To the best of our knowledge, this is the first case
report discussing the successful application of a combi-
nation of EVL and chemotherapy as the therapeutic pro-
cedure for an esophageal variceal hemorrhage in a
patient with myelofibrosis.
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